Investigation of the effect of different adjuvants on felodipine release kinetics from sustained release monolithic films

International Journal of Pharmaceutics

Volumn 131, Issue 2, 1996, Pages 183-189

  Acartürk, Füsun ^a   Şencan, Ahmet ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Adjuvants; Eudragit acrylic resin; Felodipine; Physico chemical properties; Release kinetics; Transermal film

Indexed keywords

ACRYLIC ACID RESIN; CALCIUM CHANNEL BLOCKING AGENT; DIETHYLENE GLYCOL MONOETHYL ETHER; ETHOXYDIGLYCOL; EUDRAGIT; EUDRAGIT RS; FELODIPINE; GLYCEROL; MACROGOL 1000; MACROGOL 200; MACROGOL 400; MACROGOL 600; MACROGOL DERIVATIVE; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER PROGRAM; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION COEFFICIENT; DRUG RELEASE; DRUG SOLUBILITY; FILM; KINETICS; MOISTURE; PARTITION COEFFICIENT; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; TEMPERATURE;

EID: 0342501773     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04321-7     Document Type: Article

References (21)

1. Aǧabeyoǧlu, I.T., Un Programme dans la Langue Basique de Microcomputer pour la Détermination des Donnees de Dissolution. Resumes II, XVIIIeme Semaine Medicale Balkanique. 30 Aout-4 Septembre, Istanbul, 1994, p. 327.
2. Diez, I., Colom, H., Moreno, J., Obach, R., Peraire, C. and Domenech, J., A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharm. Sci., 80 (1991) 931-934.
3. Ghebre-Sellassie, I., Gordon, R.H., Middleton, D.L., Nesbitt, R.A. and Fawzi, M.B., A unique application and characterization of Eudragit E30D film coating in sustained release formulations. Int. J. Pharm., 37 (1987) 211-218.
4. Goto, S., Kawata, M., Suzuki, T., Kim., N.S. and Ito, C., Preparation and evaluation of Eudragit gels. I: Eudragit organogels containing drugs as rectal sustained release preparations. J. Pharm. Sci., 80 (1991) 958-961.
5. Jenquin, M.R., Liebowitz, S.M., Sarabia, R.E. and McGinity, J.W., Physical and chemical factors influencing the release of drugs from acrylic resin films. J. Pharm. Sci., 79 (1990) 811-816.
6. Jenquin, M.R., Sarabia, R.E., Liebowitz, S.M. and McGinity, J.W., Relationship of film properties to drug release from monolithic films containing adjuvants. J. Pharm. Sci., 81 (1992) 983-989.
7. Kawata, M., Nakarama, M., Goto, S. and Aoyama, T., Preparation and dissolution of pattern Eudragit RS microcapsules containing Keloprofen. Chem. Pharm. Bull., 34 (1986) 2618-2623.
8. Kişlahoḡlu, M.S., Khan, M.A., Blound, C., Goettsch, R.W. and Bolton, S., Pysical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates. J. Pharm. Sci., 80 (1991) 799-804.
9. Lehmann, K., Formulation of controlled released tablets with acrylic resins. Acta Pharm. Fenn., 93 (1984) 55-74.
10. Li, S.P., Felt, K.M. and Kowarski, C.R., Preparation and evaluation of Eudragit acrylic resin for controlled drug release of pseudoephedrine HCl. Drug Dev. Ind. Pharm., 17 (1991) 1655-1683.
11. Lin, S.Y., Lee, C.J. and Lin, Y.Y., The effect of plasticizers on compatibility, mechanical properties and adhesion strength of drug-free Eudragit E Films. Pharm. Res., 8(1991) 1137-1143.
12. Ritschel, W.A. and Nayak, P.M., Evaluation in vitro and in vivo of Dimeticone transdermal therapeutic systems. Arzneim-Forsch./Drug Res., 37 (1987) 302-306.
13. Robinson, J.R. and Eriksen, P.S., Theoretical approach to sustained-release multiple-dose theraphy: noncumulative attainment of desired blood level. J. Pharm. Sci., 59 (1970) 1796-1800.
14. Sakya, T.R. and Singh, J., In vitro transport of ephedrine from matrix based transdermal formulations. Pharmazie, 46 (1991) 227-228.
15. Satyanarayana, S., Ganga, S. and Singh, J., Transport of testosterone through rat skin from transdermal patch formulations. Pharmazie, 48 (1993) 467-468.
16. Şencan, A. and Acartürk, F., A study on felodipine release kinetics from sustained release films. Proc. Int. Symp. Control. Rel. Bioact. Mater., 21 (1994) 473-474.
17. Thassu, D. and Vyas, S.P., Controlled transdermal mucolytic delivery system. Drug Dev. Ind. Pharm., 17 (1991) 561-576.
18. Ueda, M., Nakarama, Y., Makita, H. and Kawashima, Y., One continuous process of agglomeration and microencapsulation for enoxacin. Preparation method and mechanism of microencapsulation. J. Microencapsul., 10 (1993) 25-34.
19. Vyas, S.P., Gogoi, P.J. and Jain, S.K., Development and characterization of pseudolatex based transdermal drug delivery system of diclofenac. Drug Dev. Ind. Pharm., 17 (1991) 1041-1058.
20. Vyas, S.P., Jain, C.P., Gupta, S. and Uppadhayay, A., Polymeric pseudolatices dispersion bearing isosorbide dinitrate for transdermal application. Drug Dev. Ind. Pharm., 20 (1994) 101-110.
21. Yamada, M. and Tanigawara, Y., The design of membrane-controlled transdermal therapeutic systems containing molsidomine. Chem. Pharm. Bull., 35 (1987) 3407-3412.